Search filters

List of works by Thomas Kurz

3-Hydroxy-N'-arylidenepropanehydrazonamides with Halo-Substituted Phenanthrene Scaffolds Cure P. berghei Infected Mice When Administered Perorally

scientific article published on 27 June 2017

8-Aminoquinolines with an Aminoxyalkyl Side Chain Exert in vitro Dual-Stage Antiplasmodial Activity

scientific article published on 14 January 2019

Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell Lines

scientific article

Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.

scientific article

Design, Multicomponent Synthesis, and Anticancer Activity of a Focused Histone Deacetylase (HDAC) Inhibitor Library with Peptoid-Based Cap Groups

scientific article

Development of a First-in-Class Small-Molecule Inhibitor of the C-Terminal Hsp90 Dimerization

scientific article published on 27 April 2022

Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome Inhibitor

scientific article published on 08 November 2018

Effects of novel HDAC inhibitors on urothelial carcinoma cells.

scientific article published on 31 July 2018

Histone Deacetylase 6-Selective Inhibitors and the Influence of Capping Groups on Hydroxamate-Zinc Denticity

scientific article published on 17 August 2018

In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi) ⬇️

scientific article published on 03 July 2020

Isophthalic Acid-Based HDAC Inhibitors as Potent Inhibitors of HDAC8 from Schistosoma mansoni.

scientific article published on 22 June 2017

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors

scientific article published on 05 November 2020

Synthesis of Peptoid-Based Class I-Selective Histone Deacetylase Inhibitors with Chemosensitizing Properties

scientific article published on 17 December 2019

Targeting HSP90 dimerization via the C terminus is effective in imatinib-resistant CML and lacks the heat shock response

scientific article published on 03 May 2018

Paulina is supported by:

About Paulina

Help